DOI:
10.1055/s-00025479
Experimental and Clinical Endocrinology & Diabetes Reports
LinksClose Window
References
Puig-Domingo M, Soto A, Venegas E. et al.
Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.
Endocrinol Nutr 2016;
63: 397-408
We do not assume any responsibility for the contents of the web pages of other providers.